78.50 EUR

Opening hours: 09:00 - 17:30 (Central European Standard Time: 11/27/2024 3:37:10 PM)
Exchange open, closes in 1 hour 52 minutes
-0.13 EUR (-0.13%)
-1.13 EUR (-1.13%)
-5.54 EUR (-5.54%)
-22.21 EUR (-22.21%)
-17.08 EUR (-17.08%)
36.38 EUR (36.38%)
133.01 EUR (133.01%)
263.31 EUR (263.31%)

About Vetoquinol SA

Market Capitalization 945.28M

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.

Headquarters (address)

Magny-Vernois

Lure 70204

France

Phone33 3 84 62 55 55
Websitehttps://www.vetoquinol.com
Employees2,519
SectorHealthcare
IndustryDrug Manufacturers Specialty & Generic
TickerVETO
ExchangeEuropean Stock Exchange
CurrencyEUR
52 week range77.90 - 110.00
Market Capitalization945.28M
Dividend yield forward4.30 %
Dividend yield forward France (ID:70, base:257) 16.26 %
P/E trailing19.62
P/E forward16.00
Price/Sale1.76
Price/Book1.71
Beta0.949
EPS3.99
EPS France (ID:70, base:331) -1.54

Forward Annual Dividend Yield

Forward Annual Dividend Yield: Vetoquinol SA has raised their dividend 4.30 years in a row. This is below the 41466.163000 year average in the 'Drug Manufacturers Specialty & Generic' industry

Compound Average Growth Rate 3 Years

Compound Average Growth Rate 3 Years: Vetoquinol SA has raised their dividend 28.16 years in a row. This is above the 24.033000 year average in the 'Drug Manufacturers Specialty & Generic' industry

Compound Average Growth Rate 5 Years

Compound Average Growth Rate 5 Years: Vetoquinol SA has raised their dividend 11.70 years in a row. This is below the 12.576000 year average in the 'Drug Manufacturers Specialty & Generic' industry

Compound Average Growth Rate 10 Years

Compound Average Growth Rate 10 Years: Vetoquinol SA has raised their dividend 8.62 years in a row. This is below the 10.158800 year average in the 'Drug Manufacturers Specialty & Generic' industry

Payout Ratio

Payout Ratio: Vetoquinol SA has raised their dividend 21.30 years in a row. This is below the 147.817700 year average in the 'Drug Manufacturers Specialty & Generic' industry

Forward Annual Dividend Yield

Forward Annual Dividend Yield: Vetoquinol SA has raised their dividend 4.30 years in a row. This is below the 41466.163000 year average in the 'Drug Manufacturers Specialty & Generic' industry

Compound Average Growth Rate 3 Years

Compound Average Growth Rate 3 Years: Vetoquinol SA has raised their dividend 28.16 years in a row. This is above the 24.033000 year average in the 'Drug Manufacturers Specialty & Generic' industry

Compound Average Growth Rate 5 Years

Compound Average Growth Rate 5 Years: Vetoquinol SA has raised their dividend 11.70 years in a row. This is below the 12.576000 year average in the 'Drug Manufacturers Specialty & Generic' industry

Compound Average Growth Rate 10 Years

Compound Average Growth Rate 10 Years: Vetoquinol SA has raised their dividend 8.62 years in a row. This is below the 10.158800 year average in the 'Drug Manufacturers Specialty & Generic' industry

Payout Ratio

Payout Ratio: Vetoquinol SA has raised their dividend 21.30 years in a row. This is below the 147.817700 year average in the 'Drug Manufacturers Specialty & Generic' industry

CleverShares.com|
2024 ©

1.0.9097.27347